IP Library Granted Patent US 7,495,112
Granted Patent B2
US 7,495,112 · App. 11/820,788 · Granted Feb 24, 2009

Isoindoline compounds and methods of making and using the same

Assignee: Celgene Corporation
View Patent ↗
Loading inventors, assignments & file history…
Monitor This Case
Get email alerts when status or documents change.
Order Certified Copies
Most orders are placed with the USPTO same day — all within 24 business hours.
Order via The Patent Place →
Pre-filled with this patent's details
Quick Facts
Patent No.
US 7,495,112
App. No.
11/820,788
Granted
Feb 24, 2009
Kind
B2
Abstract

The invention encompasses isoindoline compounds, pharmaceutical compositions comprising them, and methods of their use for the treatment, prevention or management of various diseases and disorders. Examples include, but are not limited to, cancer, inflammatory bowel disease and myelodysplastic syndrome.

Claims (6)

1. A compound, or a pharmaceutically acceptable salt or solvate thereof, wherein the compound is:

2. A compound, or a pharmaceutically acceptable stereoisomer thereof, wherein the compound is:

3. A pharmaceutical composition comprising a compound of claim 1 or 2 .

4. The pharmaceutical composition of claim 3 , which further comprises a pharmaceutically acceptable carrier or excipient.

5. A dosage form comprising a compound of claim 1 or 2 .

6. The dosage form of claim 5 , which is suitable for oral or parenteral administration.

Assignments (1)
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Dec 4, 2019
From: CELGENE CORPORATION
To: AMGEN INC.
Reel/Frame 051181/0038 →
Continuity (2)
Division 1090027000 · Jul 28, 2004
Related Publication 20070244183A1 · Oct 18, 2007